Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Incontinence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01091727
What this trial is testing

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Sunnybrook Health Sciences Centre 57
Large-scale testing (Phase 3)Study completedNCT00255372
What this trial is testing

To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.

Who this might be right for
Chronic Constipation
Ipsen 88
Not applicableStudy completedNCT05702567
What this trial is testing

The Effectiveness of Transvaginal Radiofrequency in Women With Stress Urinary Incontinence

Who this might be right for
Urinary Incontinence,StressPelvic Floor DisordersUrinary Incontinence+1 more
José Casaña Granell 42
Not applicableLooking for participantsNCT05550675
What this trial is testing

Prospective Database of Factors Associated With Faecal vs. Double Incontinence in Patients Referred for High Resolution Anorectal Manometry.

Who this might be right for
Double IncontinenceFaecal IncontinenceUrinary Incontinence
Universitair Ziekenhuis Brussel 150
Testing effectiveness (Phase 2)UnknownNCT00762593
What this trial is testing

Trial Evaluating Transvaginal Electrical Stimulation With a Home Use Programmable Device for Urinary Stress Incontinence

Who this might be right for
Urinary Stress Incontinence
Akontis 150
Testing effectiveness (Phase 2)Study completedNCT00138749
What this trial is testing

An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

Who this might be right for
Urinary Incontinence, Stress
Pfizer 402
Large-scale testing (Phase 3)UnknownNCT01050114
What this trial is testing

OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER

Who this might be right for
Overactive Bladder
Christopher Patrick Smith 36
Not applicableActive Not RecruitingNCT03522961
What this trial is testing

Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery

Who this might be right for
Urinary Tract InfectionsPelvic Organ ProlapseUrinary Incontinence
Brigham and Women's Hospital 142
Large-scale testing (Phase 3)Study completedNCT03583372
What this trial is testing

An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).

Who this might be right for
Overactive Bladder
Urovant Sciences GmbH 506
Large-scale testing (Phase 3)Study completedNCT03438422
What this trial is testing

Effect of Pollen Extract on Urinary Incontinence

Who this might be right for
Urinary Incontinence
Dr. Santiago Palacios 160
Testing effectiveness (Phase 2)Study completedNCT01042236
What this trial is testing

Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients

Who this might be right for
Stress Urinary Incontinence
Pfizer 22
Not applicableNot Yet RecruitingNCT07212387
What this trial is testing

Sacral Neuromodulation in Patients With Double Incontinence

Who this might be right for
Double IncontinenceFaecal IncontinenceUrinary Incontinence
University Hospital Ostrava 30
Post-approval studies (Phase 4)Study completedNCT00798434
What this trial is testing

Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

Who this might be right for
Urinary Bladder, Overactive
Pfizer 794
Large-scale testing (Phase 3)Study completedNCT00912964
What this trial is testing

Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 2,030
Post-approval studies (Phase 4)Study completedNCT01018264
What this trial is testing

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease

Who this might be right for
Overactive Bladder in Parkinson's Disease
University of South Florida 23
Early research (Phase 1)Study completedNCT06593730
What this trial is testing

Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days

Who this might be right for
Faecal Incontinence
Norgine 72
Large-scale testing (Phase 3)Ended earlyNCT02660359
What this trial is testing

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2

Who this might be right for
Urinary IncontinenceOveractive Bladder
Ipsen 258
Not applicableWithdrawnNCT00522691
What this trial is testing

Efficacy of Sacral Nerve Stimulation Before Definitive Implantation

Who this might be right for
Fecal Incontinence
University of Lausanne Hospitals
Post-approval studies (Phase 4)Study completedNCT00282932
What this trial is testing

Detrol LA In Men With Overactive Bladder.

Who this might be right for
Overactive Bladder (OAB)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Testing effectiveness (Phase 2)WithdrawnNCT01297608
What this trial is testing

A Double Blinded Study to Examine the Effect of Coated Suppositories on Fecal Incontinence in Patients With Spinal Cord Injury

Who this might be right for
Fecal Incontinenece
RDD Pharma Ltd
Next Page